Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 01:31PM ET
41.90
Dollar change
-1.32
Percentage change
-3.05
%
Index- P/E- EPS (ttm)-3.46 Insider Own18.03% Shs Outstand119.56M Perf Week1.70%
Market Cap5.09B Forward P/E28.44 EPS next Y1.47 Insider Trans-3.62% Shs Float99.59M Perf Month-12.05%
Income-417.27M PEG- EPS next Q-0.28 Inst Own90.47% Short Float12.44% Perf Quarter-37.36%
Sales524.07M P/S9.70 EPS this Y79.50% Inst Trans1.72% Short Ratio8.53 Perf Half Y-14.66%
Book/sh2.20 P/B19.05 EPS next Y261.46% ROA-46.09% Short Interest12.39M Perf Year-52.85%
Cash/sh2.69 P/C15.55 EPS next 5Y33.30% ROE-122.94% 52W Range19.83 - 94.75 Perf YTD-30.00%
Dividend Est.- P/FCF- EPS past 5Y-13.70% ROI-67.96% 52W High-55.78% Beta0.96
Dividend TTM- Quick Ratio3.02 Sales past 5Y73.14% Gross Margin86.38% 52W Low111.30% ATR (14)2.47
Dividend Ex-Date- Current Ratio3.77 EPS Y/Y TTM44.89% Oper. Margin-77.11% RSI (14)38.03 Volatility4.63% 5.67%
Employees706 Debt/Eq1.62 Sales Y/Y TTM394.93% Profit Margin-79.62% Recom1.39 Target Price80.25
Option/ShortYes / Yes LT Debt/Eq1.30 EPS Q/Q65.40% Payout- Rel Volume0.34 Prev Close43.22
Sales Surprise-0.12% EPS Surprise-13.09% Sales Q/Q284.26% EarningsMay 07 BMO Avg Volume1.45M Price41.90
SMA20-7.06% SMA50-18.02% SMA200-19.17% Trades Volume319,114 Change-3.05%
Date Action Analyst Rating Change Price Target Change
Feb-05-24Upgrade Jefferies Hold → Buy $68 → $80
Dec-14-23Downgrade Wells Fargo Overweight → Equal Weight
Nov-09-23Initiated Goldman Buy $74
Nov-02-23Initiated Mizuho Neutral $42
Oct-06-23Upgrade JP Morgan Neutral → Overweight $60 → $81
Sep-15-23Upgrade Wells Fargo Equal Weight → Overweight $34 → $64
Aug-29-23Reiterated Citigroup Buy $45 → $54
Aug-03-23Downgrade JP Morgan Overweight → Neutral $72 → $60
Aug-01-23Downgrade BofA Securities Buy → Neutral $114 → $40
Jan-03-23Downgrade Wells Fargo Overweight → Equal Weight $83 → $58
May-14-24 10:02AM
08:00AM
May-09-24 05:22PM
May-08-24 12:26PM
03:13AM
11:19AM Loading…
May-07-24 11:19AM
09:30AM
08:15AM
07:56AM
07:05AM
May-06-24 07:00AM
May-01-24 07:00AM
Apr-30-24 10:00AM
Apr-26-24 10:30AM
07:15AM
07:00AM Loading…
Apr-23-24 07:00AM
Apr-04-24 04:05PM
Apr-01-24 07:00AM
Mar-28-24 11:30AM
Mar-19-24 07:01PM
Mar-17-24 08:50AM
Mar-14-24 07:02PM
Mar-11-24 07:02PM
07:00AM
Mar-06-24 04:05PM
Feb-28-24 09:35AM
09:07AM
Feb-27-24 09:30AM
08:20AM
07:51AM
07:05AM Loading…
07:05AM
Feb-26-24 07:00AM
Feb-23-24 09:27AM
Feb-20-24 12:00PM
07:00AM
Feb-14-24 09:40AM
Feb-13-24 10:00AM
Feb-06-24 04:05PM
Jan-29-24 08:48AM
Jan-26-24 07:06AM
Jan-18-24 07:59PM
Jan-17-24 05:01PM
Jan-12-24 08:36AM
Jan-09-24 10:02AM
05:45AM
Jan-08-24 09:00AM
Jan-06-24 09:02AM
Jan-05-24 04:05PM
Jan-02-24 07:00AM
Dec-28-23 07:00AM
Dec-18-23 06:17AM
Dec-15-23 08:30AM
Dec-14-23 04:06PM
09:31AM
07:28AM
07:12AM
07:00AM
05:37AM
Dec-11-23 07:00AM
Dec-06-23 04:05PM
Dec-05-23 01:34AM
Dec-04-23 10:45AM
Dec-01-23 11:31AM
Nov-21-23 07:00AM
Nov-06-23 04:05PM
Nov-04-23 01:37PM
Nov-02-23 04:59PM
11:11AM
Nov-01-23 08:25AM
07:05AM
Oct-31-23 10:42AM
08:30AM
Oct-26-23 10:02AM
09:55AM
Oct-25-23 07:00AM
06:16AM
Oct-24-23 10:39AM
Oct-20-23 08:00AM
Oct-17-23 07:00AM
Oct-11-23 01:01AM
Oct-10-23 07:45PM
09:55AM
Oct-06-23 10:30AM
09:54AM
Oct-05-23 04:05PM
07:00AM
Oct-03-23 09:43AM
Oct-02-23 07:00AM
Sep-27-23 03:10PM
Sep-25-23 07:30AM
Sep-20-23 01:01AM
Sep-11-23 09:01PM
Sep-07-23 11:30AM
Sep-06-23 04:05PM
11:54AM
11:21AM
Sep-05-23 07:00AM
Sep-01-23 11:31AM
Aug-31-23 11:31AM
Aug-30-23 11:30AM
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Deschatelets PascalChief Scientific OfficerMay 08 '24Option Exercise4.3178,907340,0891,194,890May 09 05:15 PM
Deschatelets PascalChief Scientific OfficerMay 08 '24Sale42.3578,9073,341,8481,115,983May 09 05:15 PM
Dunlop A. SinclairDirectorApr 12 '24Option Exercise13.191,50019,785133,518Apr 15 04:09 PM
Deschatelets PascalChief Scientific OfficerApr 08 '24Option Exercise3.7669,107259,8421,185,090Apr 09 04:25 PM
Deschatelets PascalChief Scientific OfficerApr 08 '24Sale54.1769,1073,743,6051,115,983Apr 09 04:25 PM
Sullivan Timothy EugeneChief Financial OfficerApr 01 '24Option Exercise10.034,00040,12097,338Apr 02 04:06 PM
Sullivan Timothy EugeneChief Financial OfficerApr 01 '24Sale58.664,000234,64093,338Apr 02 04:06 PM
Dunlop A. SinclairDirectorMar 19 '24Sale57.1818,6811,068,161173,998Mar 20 05:18 PM
DeLong Mark JeffreyChief Business & Strat OfficerMar 18 '24Sale56.909,913564,05054,693Mar 19 04:03 PM
Chopas James GeorgeVP/Chief Accounting OfficerMar 15 '24Sale56.4618410,38938,883Mar 18 04:19 PM
Nicholson NurChief Technical OfficerMar 13 '24Sale57.5611,220645,83856,287Mar 14 04:17 PM
Deschatelets PascalChief Scientific OfficerMar 08 '24Option Exercise3.6769,107253,6231,185,090Mar 11 04:08 PM
Deschatelets PascalChief Scientific OfficerMar 08 '24Sale62.1969,1074,297,5491,115,983Mar 11 04:08 PM
Watson David O.General CounselMar 06 '24Option Exercise13.853,76252,104107,152Mar 08 07:45 AM
Francois CedricChief Executive OfficerMar 01 '24Option Exercise4.20250,0001,050,000563,662Mar 05 04:07 PM
Sullivan Timothy EugeneChief Financial OfficerMar 01 '24Option Exercise10.036,00060,18099,338Mar 05 04:04 PM
Francois CedricChief Executive OfficerMar 01 '24Sale64.11250,00016,028,706313,662Mar 05 04:07 PM
Sullivan Timothy EugeneChief Financial OfficerMar 01 '24Sale63.226,000379,34093,338Mar 05 04:04 PM
Francois CedricChief Executive OfficerFeb 12 '24Sale67.773,962268,492313,662Feb 13 04:49 PM
Sullivan Timothy EugeneChief Financial OfficerFeb 12 '24Sale67.771,43196,97493,338Feb 13 04:59 PM
Townsend Adam J.Chief Commercial OfficerFeb 12 '24Sale67.771,14877,79692,453Feb 13 05:05 PM
Deschatelets PascalChief Scientific OfficerFeb 12 '24Sale67.771,14877,7961,115,983Feb 13 04:43 PM
Watson David O.General CounselFeb 12 '24Sale67.7778152,926103,390Feb 13 05:06 PM
DeLong Mark JeffreyChief Business & Strat OfficerFeb 12 '24Sale67.7759740,45764,606Feb 13 04:38 PM
Eisele JeffreyChief Development OfficerJan 30 '24Sale65.5397163,63057,208Jan 31 04:23 PM
Lewis KarenChief People OfficerJan 30 '24Sale65.5388357,86346,387Jan 31 04:28 PM
Francois CedricChief Executive OfficerJan 29 '24Sale64.142,843182,345317,624Jan 31 04:26 PM
Townsend Adam J.Chief Commercial OfficerJan 29 '24Sale64.1490658,10993,601Jan 31 04:36 PM
Sullivan Timothy EugeneChief Financial OfficerJan 29 '24Sale64.1490658,10994,769Jan 31 04:34 PM
Watson David O.General CounselJan 29 '24Sale64.1490658,109104,171Jan 31 04:38 PM
Deschatelets PascalChief Scientific OfficerJan 29 '24Sale64.1487456,0571,117,131Jan 31 04:21 PM
Nicholson NurChief Technical OfficerJan 29 '24Sale64.1483553,55567,507Jan 31 04:31 PM
DeLong Mark JeffreyChief Business & Strat OfficerJan 29 '24Sale64.1436723,53965,203Jan 31 04:18 PM
Lewis KarenChief People OfficerJan 29 '24Sale64.1436723,53947,270Jan 31 04:28 PM
Eisele JeffreyChief Development OfficerJan 29 '24Sale64.1427917,89558,179Jan 31 04:23 PM
Eisele JeffreyChief Development OfficerJan 23 '24Sale63.697,378469,90558,458Jan 24 04:03 PM
Lewis KarenChief People OfficerJan 23 '24Sale63.694,286272,97547,637Jan 24 04:06 PM
Francois CedricChief Executive OfficerJan 22 '24Sale65.0013,431872,961320,467Jan 23 07:28 PM
Watson David O.General CounselJan 22 '24Sale65.004,184271,943105,077Jan 23 06:17 PM
Deschatelets PascalChief Scientific OfficerJan 22 '24Sale65.003,913254,3291,118,005Jan 23 06:03 PM
Sullivan Timothy EugeneChief Financial OfficerJan 22 '24Sale65.003,551230,80195,675Jan 23 06:13 PM
Townsend Adam J.Chief Commercial OfficerJan 22 '24Sale65.003,413221,83194,507Jan 23 06:15 PM
Nicholson NurChief Technical OfficerJan 22 '24Sale65.002,593168,53568,342Jan 23 06:11 PM
Lewis KarenChief People OfficerJan 22 '24Sale65.001,738112,96351,923Jan 23 06:07 PM
Eisele JeffreyChief Development OfficerJan 22 '24Sale65.001,607104,44965,836Jan 23 06:05 PM
DeLong Mark JeffreyChief Business & Strat OfficerJan 22 '24Sale65.001,38489,95465,570Jan 23 06:01 PM
Chopas James GeorgeVP/Chief Accounting OfficerJan 22 '24Sale65.001,06168,96139,067Jan 23 06:00 PM
Eisele JeffreyChief Development OfficerJan 17 '24Sale65.585,207341,47567,443Jan 18 04:55 PM
Lewis KarenChief People OfficerJan 17 '24Sale65.583,276214,84053,661Jan 18 04:54 PM
Francois CedricChief Executive OfficerJan 16 '24Sale66.817,851524,514333,898Jan 17 04:32 PM
Watson David O.General CounselJan 16 '24Sale66.814,240283,268109,261Jan 17 04:38 PM
Sullivan Timothy EugeneChief Financial OfficerJan 16 '24Sale66.812,235149,31799,226Jan 17 04:36 PM
Townsend Adam J.Chief Commercial OfficerJan 16 '24Sale66.812,235149,31797,920Jan 17 04:37 PM
Nicholson NurChief Technical OfficerJan 16 '24Sale66.811,857124,06470,935Jan 17 04:40 PM
Deschatelets PascalChief Scientific OfficerJan 16 '24Sale66.811,632109,0321,121,918Jan 17 04:47 PM
Lewis KarenChief People OfficerJan 16 '24Sale66.811,632109,03256,937Jan 17 04:43 PM
DeLong Mark JeffreyChief Business & Strat OfficerJan 16 '24Sale66.811,631108,96566,954Jan 17 04:41 PM
Chopas James GeorgeVP/Chief Accounting OfficerJan 16 '24Sale66.8186457,72340,128Jan 17 04:45 PM
Eisele JeffreyChief Development OfficerJan 16 '24Sale66.8143829,26272,650Jan 17 12:24 PM
Baumal CarolineChief Medical OfficerJan 04 '24Sale60.052,751165,20732,931Jan 05 04:14 PM
Eisele JeffreyChief Development OfficerDec 27 '23Sale60.2323514,15453,580Dec 28 04:13 PM
Eisele JeffreyChief Development OfficerDec 26 '23Sale57.86683,93553,815Dec 28 04:13 PM
Watson David O.General CounselDec 19 '23Option Exercise13.857,905109,48493,658Dec 20 04:18 PM
Watson David O.General CounselDec 19 '23Sale57.233,905223,47289,753Dec 20 04:18 PM
Dunlop A. SinclairDirectorDec 14 '23Option Exercise13.196,27482,754128,677Dec 15 04:04 PM
Townsend Adam J.Chief Commercial OfficerDec 01 '23Option Exercise15.09110,0001,659,900186,407Dec 05 07:29 PM
SCHEIBLER LUKASChief Research OfficerDec 01 '23Option Exercise13.8510,000138,50078,299Dec 05 07:40 PM
Townsend Adam J.Chief Commercial OfficerDec 01 '23Sale60.81110,0006,689,30376,407Dec 05 07:29 PM
Dunlop A. SinclairDirectorDec 01 '23Sale61.1324,0001,467,240192,679Dec 05 04:21 PM
SCHEIBLER LUKASChief Research OfficerDec 01 '23Sale60.0010,000600,00068,299Dec 05 07:40 PM
Sullivan Timothy EugeneChief Financial OfficerNov 30 '23Option Exercise10.0314,158142,00591,871Dec 01 04:11 PM
Sullivan Timothy EugeneChief Financial OfficerNov 30 '23Sale54.7314,158774,88477,713Dec 01 04:11 PM
Francois CedricChief Executive OfficerNov 21 '23Sale48.805,000244,000269,655Nov 21 05:36 PM
Machiels AlecDirectorNov 17 '23Option Exercise2.671,2503,338368,670Nov 20 04:18 PM
Dunlop A. SinclairDirectorNov 17 '23Sale49.998,894444,620122,403Nov 21 04:36 PM
Machiels AlecDirectorNov 17 '23Sale47.741,25059,675367,420Nov 20 04:18 PM
Deschatelets PascalChief Scientific OfficerNov 14 '23Option Exercise3.7645,000169,2001,116,807Nov 15 04:10 PM
Deschatelets PascalChief Scientific OfficerNov 08 '23Option Exercise2.6717,49446,7091,083,807Nov 09 04:18 PM
Deschatelets PascalChief Scientific OfficerNov 08 '23Sale47.2712,000567,2401,071,807Nov 09 04:18 PM
Chopas James GeorgeVP/Chief Accounting OfficerOct 23 '23Sale46.041326,07732,680Oct 24 04:20 PM
DeLong Mark JeffreyChief Business & Strat OfficerOct 23 '23Sale46.041316,03151,622Oct 24 04:18 PM
Machiels AlecDirectorOct 17 '23Option Exercise2.671,2503,338368,670Oct 18 05:43 PM
Dunlop A. SinclairDirectorOct 17 '23Sale49.0024,0001,176,000216,679Nov 21 04:00 PM
Machiels AlecDirectorOct 17 '23Sale48.501,25060,625367,420Oct 18 05:43 PM
Deschatelets PascalChief Scientific OfficerOct 09 '23Option Exercise2.6718,50049,3951,078,313Oct 10 04:26 PM
Deschatelets PascalChief Scientific OfficerOct 09 '23Sale40.3812,000484,5601,066,313Oct 10 04:26 PM
Nicholson NurChief Technical OfficerSep 18 '23Option Exercise29.769,719289,23773,634Sep 19 05:03 PM
Machiels AlecDirectorSep 18 '23Option Exercise2.671,2503,338368,670Sep 19 05:05 PM
Nicholson NurChief Technical OfficerSep 18 '23Sale44.2720,350900,81353,284Sep 19 05:03 PM
Machiels AlecDirectorSep 18 '23Sale45.001,25056,250367,420Sep 19 05:05 PM
Machiels AlecDirectorSep 15 '23Option Exercise2.671,2503,338368,670Sep 18 04:24 PM
Machiels AlecDirectorSep 15 '23Sale45.341,25056,675367,420Sep 18 04:24 PM
Deschatelets PascalChief Scientific OfficerSep 08 '23Option Exercise2.6718,50049,3951,071,813Sep 11 04:58 PM
Deschatelets PascalChief Scientific OfficerSep 08 '23Sale42.8712,000514,4401,059,813Sep 11 04:58 PM
SCHEIBLER LUKASChief Research OfficerSep 06 '23Sale43.011,75675,52668,299Sep 07 04:08 PM
Francois CedricChief Executive OfficerSep 01 '23Option Exercise2.67300,000801,000574,655Sep 01 04:05 PM
Francois CedricChief Executive OfficerSep 01 '23Sale41.75150,0006,262,959424,655Sep 01 04:05 PM
Chopas James GeorgeVP/Chief Accounting OfficerAug 31 '23Sale41.2355122,71630,312Sep 01 04:08 PM
Deschatelets PascalChief Scientific OfficerAug 08 '23Option Exercise2.6718,50049,3951,065,313Aug 09 04:08 PM
Deschatelets PascalChief Scientific OfficerAug 08 '23Sale23.6612,000283,9201,053,313Aug 09 04:08 PM